Press release
CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is pleased to announce the launch of its new line of Circulatory System Tissue Microarrays [https://www.bioimagingtech.com/circulatory-system-tissue-microarrays.html] to the scientific community. This new product line offers researchers a powerful tool to study a wide range of diseases affecting the heart, blood vessels, and spleen.
CD BioSciences is committed to providing researchers with a comprehensive range of reliable imaging products and analysis services that enable them to make significant contributions to biomedical research. By offering a comprehensive selection of Circulatory System Tissue Microarrays with diverse patient samples and disease states, CD BioSciences aims to empower researchers to gain deeper insights into these critical areas of human health and conduct more efficient and comprehensive studies.
These new Circulatory System Tissue Microarrays, including Heart & Vascular Tissue Microarrays and Spleen Tissue Microarrays, are designed to accelerate research into heart disease, vascular disorders, and other conditions affecting the circulatory system. Each tissue microarray is constructed from paraffin-embedded (FFPE) tissue blocks from a specific number of donor cases. Additionally, the microarrays come in various configurations, with a range of cases and core numbers per case, allowing researchers to tailor their experiments to their specific needs.
For example, the Multiple Parts of Artery Tissue and Atherosclerosis Tissue Microarray, 30 Cases, 22 Cores (Catalog # CSCT001) consist of various sections of artery tissue and atherosclerosis tissue and can be used in IHC, ISH and other routine histology procedures. This tissue microarray includes various artery tissues (coronary, aorta, etc.) and atherosclerosis samples. Each tissue has one core. This offering accelerates researchers' studies of diseases related to arterial tissue.
Another example is the Cardiovascular Disease Tissue Microarray, 48 Cases, 24 Cores (Catalog # CSCT003), which consists of samples of cardiovascular disease tissue. It comprises 9 cases of cardiovascular tumor, 7 cases of cardiovascular disease, and 9 samples of normal cardiovascular tissue. Each case has duplicate cores. This new product offers researchers a valuable tool for studying various cardiovascular diseases.
In addition, the Heart Disease Spectrum Tissue Microarray, 100 Cases, 50 Cores (Catalog # CSCT004) contains samples of cardiac tumor tissue. It provides 1 case of mesothelioma, 5 cases of myxoma, 20 cases of valvular disease, 5 cases of inflammation, 2 samples of adjacent normal tissue, and 17 samples of normal tissue. This innovative product is designed to accelerate research into heart disease, vascular disorders, and other conditions affecting the circulatory system.
By providing researchers with a convenient and efficient way to analyze samples, CD BioSciences team hopes to contribute to the development of new diagnostic tools and therapeutic strategies. To find detailed information about each product, including the number of cases and cores per microarray, please visit https://www.bioimagingtech.com/circulatory-system-tissue-microarrays.html.
About CD BioSciences
CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.
Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-biosciences-announces-comprehensive-circulatory-system-tissue-microarrays]
State: New York
Country: United States
Website: https://www.bioimagingtech.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays here
News-ID: 3551586 • Views: …
More Releases from ABNewswire
Kinghelm Antennas Power OBD Applications in Smart and New Energy Vehicles
Kinghelm, a leading RF and microwave technology company, provides high-performance antennas and connectors for OBD systems in smart and new energy vehicles. Together with partners Slkor Semiconductor and Avant Electronics, Kinghelm delivers integrated solutions for GPS/BDS positioning, Bluetooth/Wi-Fi transmission, and intelligent vehicle connectivity.
Image: https://www.abnewswire.com/upload/2025/10/0790f023c90e731790a4ec80533af9ea.jpg
Automotive OBD Products and Application Scenarios
As intelligent connected vehicles become increasingly mainstream, On-Board Diagnostics (OBD) systems have emerged as a vital component for ensuring driving safety, emissions…
Limbal Stem Cells Deficiency Market Analysis 2034 - Competitive Landscape, Clini …
In 2023, the Limbal Stem Cell Deficiency market was largest in the US ( almost equal to USD 1,500 million) and smallest in Spain ( almost equal to USD 127 million) a trend expected to continue through the forecast period. The US had 103,000 diagnosed cases, while Japan had 37,000, both projected to grow. Within EU4 and the UK, Germany recorded the highest number of diagnosed cases - about 15,000…
Patient Monitoring Devices Market Projected to Grow at 11% CAGR: Advanced AI Int …
The patient monitoring devices market is poised for substantial growth, driven by the rising prevalence of chronic diseases and increasing preference for remote healthcare solutions. The market is expanding with significant innovations from key players, including Medtronic plc, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare, Smiths Medical, Hillrom, and Mindray Medical International, among others.
DelveInsight's "Patient Monitoring Devices - Market Insight, Competitive Landscape,…
Primary Biliary Cholangitis Treatment Projected to Grow Significantly Through 20 …
The primary biliary cholangitis market is experiencing significant growth, driven by improved diagnostic capabilities, and the introduction of new therapeutic options. Key companies involved in the primary biliary cholangitis market include Gilead Sciences, Intercept Pharmaceuticals, CymaBay Therapeutics, COUR Pharmaceuticals, Teva Pharmaceutical, Mylan, AbbVie, Glenmark Pharmaceuticals, and Allergan. These companies are actively working to meet the substantial unmet needs in this area.
DelveInsight's "Primary Biliary Cholangitis Market Insight, Epidemiology, and Market Forecast…
More Releases for BioSciences
Nanostructured Drug Market Poised for Growth with Advancements in Targeted Deliv …
Nanostructured Drug Market Overview
Nanostructured Drug Market is projected to grow significantly during the forecast period, driven by advancements in nanotechnology and increasing demand for targeted drug delivery systems.
The latest report (2025-2032) on the Nanostructured Drug Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also…
CRISPR-Based Diagnostics Market for Infectious Diseases & Cancer Detection By 20 …
Global CRISPR-Based Diagnostics Market reached at a CAGR during the forecast period 2024-2031.
Crispr-Based Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate…
CRISPR-Based Diagnostics Market: Global Type, Trends, Service, Growth, Opportuni …
The CRISPR-Based Diagnostics Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/crispr-based-diagnostics-market
What is the projected…
CRISPR Based Diagnostics Market Growing Rapidly by 2031 - Sherlock Biosciences, …
DataM Intelligence has published a new research report on "CRISPR Based Diagnostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF…
Glycated Albumin Market to See Booming Growth 2024-2031 | Lifespan Biosciences, …
Glycated Albumin Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Glycated Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Glycated Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
Congenital Adrenal Hyperplasia Market to Witness Growth by 2032, Estimates Delve …
DelveInsight's "Congenital Adrenal Hyperplasia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Congenital Adrenal Hyperplasia, historical and forecasted epidemiology as well as the Congenital Adrenal Hyperplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Congenital Adrenal Hyperplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here:
https://www.delveinsight.com/sample-request/congenital-adrenal-hyperplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of…
